Showing results (1991-2000 of 8,157) with videos related to

Sort By:
Pageof 816
Haematologica|August 18, 2026
Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complicationsCaitlin Unkenholz, Sofía Huerga, Alison Moskowitz, et al.
Haematologica|August 18, 2026
A novel KMT2A::AFF1-derived fusion circRNA regulates mitochondrial metabolism in t(4;11) B-cell acute lymphoblastic leukemiaDoron Tolomeo, Michela Bardini, Santina Venuto, et al.
Haematologica|August 20, 2026
Venetoclax-azacitidine treatment in TTMV::RARA-driven acute myeloid leukemia mimicking acute promyelocytic leukemiaLu Zhao, Zhanwang Zhu, Bihui Yang, et al.
Haematologica|August 20, 2026
Venetoclax combined with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia: outcomes and risk stratificationAndrew F Berdel, Christoph Röllig, Clara Burkhard-Meier, et al.
Haematologica|August 20, 2026
Navigating murky waters: risk scores for nodular lymphocyte-predominant Hodgkin lymphomaEmily J Smith, Michael Sargent Binkley
Haematologica|July 23, 2026
Rapid recovery and functional resilience of bone marrow function post B-cell acute lymphoblastic leukemiaChristina T Jensen, Erik Hultin, Stefan Lang, et al.
Haematologica|August 27, 2026
CD19 antigen: from tumor target to safety switch in CAR-T cell therapySimona Manni, Laura Iaffaldano, Maria Cecilia Quadraccia, et al.
Haematologica|August 27, 2026
Rethinking intensive salvage therapy in the venetoclax eraJesse M Tettero, David C De Leeuw
Haematologica|August 27, 2026
Divergent roles of interleukin-12p40 and interleukin-18 in severe fibrosing chronic graft-versus-host-disease, immunity, and post-transplant outcomesSalim Oulghazi, Lina Alasfar, Mark Robinson, et al.
Haematologica|August 27, 2026
Longitudinal single-cell analysis reveals dynamic clonal competition and convergent evolution shaped by therapy sequencing in a young patient with chronic lymphocytic leukemiaAnna Panovska, Tomas Arpas, Adela Prchlikova, et al.
Pageof 816